TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

Clinical trial NCT00203320 · COMPLETED

Trial details

NCT number: NCT00203320
Sponsor: Tobinick, Edward Lewis, M.D.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2005-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.